Research reveals high stability of hepatitis B viruses

NewsGuard 100/100 Score

At room temperature, hepatitis B viruses (HBV) remain contagious for several weeks and they are even able to withstand temperatures of four degrees centigrade over the span of nine months. When applied properly, disinfectants are effective - but only undiluted. These are the results gained by a German-Korean research team in a study using a novel HBV infection system in human liver cells. Due to a lack of human research models, research had previously been conducted in duck hepatitis B viruses. Professor Eike Steinmann from the Department for Molecular & Medical Virology at Ruhr-Universität Bochum (RUB) and RUB alumnus Professor Marc Windisch from the Institute Pasteur Korea in Seoul published their report in the Journal of Infectious Diseases on october 24, 2018.

Recurring infections

Hepatitis B is primarily transmitted through contact with blood. "Consequently, it should be easy to control, provided appropriate hygiene measures are implemented," says Eike Steinmann. However, there are frequently cases of people contracting the hepatitis B virus in hospitals or in the workplace.

Previously: duck viruses only

Attempting to find out why, researchers had hitherto been forced to make use of the duck hepatitis B virus, which is related to the human virus. "However, those studies have only ever permitted rough estimates as far as the infectiosity of HBV is concerned," points out Steinmann. For their analyses, he and his colleagues utilised an HBV infection system in human liver cells, developed recently at the Institute Pasteur Korea, in order to obtain more realistic results. "The new HBV infection system enables researchers worldwide to finally conduct highly detailed studies of the human virus that had not been possible until quite recently," explains Marc Windisch.

Common hand disinfectants are effective

Using this model, the researchers were able to demonstrate that the infectivity of HBV barely decreases at room temperature even after a few weeks, and that it remains highly stable at four degrees centigrade over a period of nine months. "Various alcohols and off-the-shelf hand sanitizers deactivate the viruses," says Eike Steinmann. "If the disinfectants are diluted, however, their deactivating properties are reduced. Luckily, diluting disinfectants is not common practice."

More resilient than all others

The researchers compared the efficacy of two alcohol-based WHO-recommended hand sanitizers against different viruses that have an envelope, such as the HBV. The comparison viruses included the Ebola virus and the hepatitis C virus. "Among all tested viruses, HBV demonstrated the highest resilience against both disinfectants," stresses Marc Windisch, Head of the Applied Molecular Virology Laboratory at the Institute Pasteur in Seoul.
The researchers recommend strict compliance with hygiene guidelines, in order to prevent HBV infections in the future.

Hepatitis B

Worldwide, approx. 290 million people are chronically infected with the hepatitis B virus. This means hepatitis B is one of the most widely spread infectious diseases. The virus can cause both acute and chronic liver diseases. Due to the consequences of severe liver diseases, the virus leads to great number of deaths each year.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New vaccine strategy targets SARS-CoV-2's stable S2 subunit, offering broad protection against evolving variants